MVB vs ATOM vs DRUG — overlap, fees and exposure compared

MVB, ATOM and DRUG hold at least 115 companies between them. None is in every one of them, and MVB and ATOM are the most alike: 0% of each is the same companies.

Side by side

MVB ATOM DRUG

FundVanEckGlobal XBetaShares

Asset classSector & thematicSector & thematicSector & thematic

Fee a year0.28%0.69%0.57%

Fund size$279.0m$152.0m$163.0m

Holdings85866

1Y price return−5.0%−32.1%+6.6%

Distribution yield4.53%9.28%3.91%

Look-through coverage100.0%90.5%99.7%

Return, last year

change since the start

share of each fund

MVB
ATOM
DRUG

CCO CAMECO CORPIn 1 of 3MVBnot heldATOM22.0%DRUGnot held
ANZ ANZ GROUP HOLDINGS LIMITEDIn 1 of 3MVB20.7%ATOMnot heldDRUGnot held
NAB NATIONAL AUSTRALIA BANK LIMITEDIn 1 of 3MVB20.2%ATOMnot heldDRUGnot held
WBC WESTPAC BANKING CORPORATIONIn 1 of 3MVB20.2%ATOMnot heldDRUGnot held
CBA COMMONWEALTH BANK OF AUSTRALIA.In 1 of 3MVB19.2%ATOMnot heldDRUGnot held

and 105 more companies the funds hold

How alike they are

Keep going

See MVB + ATOM + DRUG as one portfolioEvery company, where you'd own it twice What moved MVB this monthIts biggest gains and falls, by company